Kiromic Biopharma, Inc.

Kiromic Biopharma, Inc. company information, Employees & Contact Information

Kiromic BioPharma is an allogeneic Gamma Delta T-cell therapy company featuring  unique, proprietary, end-to-end bioinformatic, AI targeting, and manufacturing technologies to address solid tumors. We are a clinical-stage, fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence (AI) 2.0 target discovery engine to develop and commercialize cell therapies focusing on immuno-oncology. Kiromic is developing a multi-indication allogeneic cell therapy platform that exploits the natural potency of Gamma Delta T-cells to target solid tumors. Kiromic’s DIAMOND® AI is where data science meets target identification to dramatically compress the years and hundreds of millions of dollars required to develop a live drug. The Company maintains offices in Houston, Texas. To learn more, visit www.kiromic.com and connect with us on Twitter and LinkedIn. OTCB: KRBP

Company Details

Employees
25
Address
7707 Fannin Street,
Phone
806-252-5845
Email
cu****@****mic.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Houston, TX
Looking for a particular Kiromic Biopharma, Inc. employee's phone or email?

Kiromic Biopharma, Inc. Questions

News

Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation - Business Wire

Kiromic BioPharma Announces Settlement of Previously Disclosed SEC Investigation Business Wire

Kiromic BioPharma’s NSCLC T-cell Therapy Deltacel Continues to Provide Disease Stabilization in Updated Data - CGTLive®

Kiromic BioPharma’s NSCLC T-cell Therapy Deltacel Continues to Provide Disease Stabilization in Updated Data CGTLive®

Kiromic furloughs 'substantially all' workers amid cash crunch, leaving 31 staff without pay - Fierce Biotech

Kiromic furloughs 'substantially all' workers amid cash crunch, leaving 31 staff without pay Fierce Biotech

Kiromic BioPharma Appoint Pamela Misajon and Michael Catlin to its Board of Directors - citybiz

Kiromic BioPharma Appoint Pamela Misajon and Michael Catlin to its Board of Directors citybiz

Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation - Stock Titan

Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation Stock Titan

Houston-based Kiromic BioPharma finds buyer for assets after filing Chapter 7 - The Business Journals

Houston-based Kiromic BioPharma finds buyer for assets after filing Chapter 7 The Business Journals

SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews - Newsfile

SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews Newsfile

User - FinancialContent

User FinancialContent

Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01, Company’s Phase 1 Cell Therapy Cancer Vaccine Candidate for Solid Tumors - Business Wire

Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01, Company’s Phase 1 Cell Therapy Cancer Vaccine Candidate for Solid Tumors Business Wire

Top Kiromic Biopharma, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant